ארצות הברית - אנגלית - NLM (National Library of Medicine)

par pharmaceutical, inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - emoquette® (desogestrel and ethinyl estradiol tablets) are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant system depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. in a clinical trial with desogestrel and ethinyl estradiol tablets, 1,195 subjects completed 11,656 cycles and a total of 10 pregnancies were reported. this represents an overall user-efficacy (typical user-efficacy) pregnancy rate of 1.12 per 100 women-years. this rate includes patients who did not take the drug correctly. chancef 85 85 spermicidesg 26 6 40  calendar  ovulation method  sympto-thermalh  post-ovulation withdrawal 19 4

ארצות הברית - אנגלית - NLM (National Library of Medicine)

bryant ranch prepack - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - isibloomtm (desogestrel and ethinyl estradiol tablets) are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant system depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. in a clinical trial with desogestrel and ethinyl estradiol tablets, 1,195 subjects completed 11,656 cycles and a total of 10 pregnancies were reported. this represents an overall user-efficacy (typical user-efficacy) pregnancy rate of 1.12 per 100 women-years. this rate includes patients who did not take the drug correctly. chancef 85 85 spermicidesg 26 6 40 periodic abstinence 25 63   calendar 9   ovulation method 3   sympto-thermalh 2   post-ovulation 1 withdrawal 19 4 capi   parous women 40 26 42   nulliparous women 20 9 56 sponge   parous women 40 20 42   nulliparous women 20 9 56 diaphragmi 20 6 56 condomj   female (reality® ) 21 5 56   male 14 3 61 pill 5 71   progestin only 0.5   combined 0.1 iud   progesterone t 2 1.5 81   copper t380a 0.8 0.6 78   lng 20 0.1 0.1 81 depo-provera 0.3 0.3 70 norplant® and norplant-2® 0.05 0.05 88 female sterilization 0.5 0.5 100 male sterilization 0.15 0.10 100 emergency contraceptive pills: treatment initiated within 72 hours after unprotected intercourse reduces the risk of pregnancy by at least 75%.d lactation amenorrhea method: lam is a highly effective, temporary method of contraception.e source: trussel j. contraceptive efficacy. in hatcher ra, trussell j, stewart f, cates w, stewart gk, kowel d, guest f, contraceptive technology: seventeenth revised edition. new york, ny; irvington publishers, 1998. a among couples attempting to avoid pregnancy, the percentage who continue to use a method for one year. b among typical couples who initiate use of a method (not necessarily for the first time), the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason. c among couples who initiate use of a method (not necessarily for the first time) and who use it perfectly (both consistently and correctly), the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason. d the treatment schedule is one dose within 72 hours after unprotected intercourse, and a second dose 12 hours after the first dose. the fda has declared the following brands of oral contraceptives to be safe and effective for emergency contraception: ovral® (1 dose is 2 white pills), alesse® (1 dose is 5 pink pills), nordette® or levlen® (1 dose is 4 yellow pills). e however, to maintain effective protection against pregnancy, another method of contraception must be used as soon as menstruation resumes, the frequency of duration of breastfeeds is reduced, bottle feeds are introduced, or the baby reaches 6 months of age. f the percents becoming pregnant in columns (2) and (3) are based on data from populations where contraception is not used and from women who cease using contraception in order to become pregnant. among such populations, about 89% become pregnant within one year. this estimate was lowered slightly (to 85%) to represent the percent who would become pregnant within one year among women now relying on reversible methods of contraception if they abandoned contraception altogether. g foams, creams, gels, vaginal suppositories, and vaginal film. h cervical mucus (ovulation) method supplemented by calendar in the pre-ovulatory and basal body temperature in the post-ovulatory phases. i with spermicidal cream or jelly. j without spermicides. desogestrel and ethinyl estradiol tablets have not been studied for and are not indicated for use in emergency contraception. isibloom is contraindicated in females who are known to have or develop the following conditions:

הולנד - הולנדית - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

centrafarm b.v. - desogestrel; ethinylestradiol; - tablet - desogestrel and ethinylestradiol

הולנד - הולנדית - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

centrafarm b.v. - desogestrel; ethinylestradiol; - tablet - desogestrel and ethinylestradiol

פורטוגל - פורטוגלית - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

stragen nordic a/s - desogestrel + etinilestradiol - comprimido - 0.15 mg + 0.02 mg - desogestrel 0.15 mg ; etinilestradiol 0.02 mg - desogestrel and ethinylestradiol - genérico - duração do tratamento: longa duração

פורטוגל - פורטוגלית - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

stragen nordic a/s - desogestrel + etinilestradiol - comprimido - 0.15 mg + 0.02 mg - desogestrel 0.15 mg ; etinilestradiol 0.02 mg - desogestrel and ethinylestradiol - genérico - duração do tratamento: longa duração

ארצות הברית - אנגלית - NLM (National Library of Medicine)

aurobindo pharma limited - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - desogestrel 0.15 mg - kalligatm tablets are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant system depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. in a clinical trial with kalligatm , 1,195 subjects completed 11,656 cycles and a total of 10 pregnancies were reported. this represents an overall user-efficacy (typical user-efficacy) pregnancy rate of 1.12 per 100 women-years. this rate includes patients who did not take the drug correctly. emergency contraceptive pills: treatment initiated within 72 hours after unprotected intercourse reduces the risk of pregnancy by at least 75%.§ lactation amenorrhea method: lam is

צרפת - צרפתית - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

cristers - désogestrel 0; éthinylestradiol 0 - comprimé - 0,15 mg - pour un comprimé > désogestrel 0,15 mg > éthinylestradiol 0,02 mg - progestatifs et estrogènes en association fixe - classe pharmacothérapeutique : progestatifs et estrogènes en association fixe,code atc : g03aa09.contraceptif estroprogestatif.(g : système génito-urinaire et hormones sexuelles)desogestrel/ethinylestradiol cristers, comprimé pelliculé est un contraceptif hormonal oral.il empêche l'ovulation et est préconisé dans le but d'éviter une grossesse.chaque comprimé blanc contient deux substances actives (éthinylestradiol et désogestrel).les contraceptifs oraux qui contiennent deux substances à activité hormonale sont appelés contraceptifs oraux « combinés ».

צרפת - צרפתית - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

cristers - désogestrel 0; éthinylestradiol 0 - comprimé - 0,15 mg - pour un comprimé > désogestrel 0,15 mg > éthinylestradiol 0,03 mg - progestatifs et estrogènes en association fixe - classe pharmacothérapeutique : progestatifs et estrogènes en association fixe,code atc : g03aa09.contraceptif estroprogestatif.(g : système génito-urinaire et hormones sexuelles)desogestrel/ethinylestradiol cristers, comprimé pelliculé est un contraceptif hormonal oral.il empêche l'ovulation et est préconisé dans le but d'éviter une grossesse. chaque comprimé blanc contient deux substances actives (éthinylestradiol et désogestrel).les contraceptifs oraux qui contiennent deux substances à activité hormonale sont appelés contraceptifs oraux « combinés ».

פורטוגל - פורטוגלית - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

stragen nordic a/s - desogestrel + etinilestradiol - comprimido - 0.15 mg + 0.02 mg - desogestrel 0.15 mg ; etinilestradiol 0.02 mg - desogestrel and ethinylestradiol - genérico - duração do tratamento: longa duração